CARL — CARLSMED, INC.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1794546 ·
Last close
$11.89
Market Cap
$323.23M
52W High
$15.19
52W Low
$8.50
ADV30
200,679
Next earnings
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 16,116,000 12,425,000 -9,276,000 -8,696,000 118,769,000 73,016,000 26,521,000
Dec 2025 15,165,000 11,608,000 -9,318,000 -8,613,000 130,120,000 85,793,000 31,251,000
Sep 2025 13,074,000 9,927,000 -9,035,000 -8,526,000 134,863,000 115,373,000 28,203,000
Jun 2025 12,083,000 8,869,000 -6,502,000 -6,766,000 53,270,000 33,472,000 136,343,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-28,977,000
Investing CF
$-25,483,000
Financing CF
$100,128,000
CapEx
$-1,357,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-2.52
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-100,805,000
Inventory
$1,845,000
Receivables
$11,362,000
ST Investments
$24,000,000
EBIT TTM
$-28,204,000
Pretax Income TTM
$-29,634,000
Interest Exp TTM
$1,430,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$56,438,000
EBITDA
$-33,791,000
Free Cash Flow
$-26,400,876
Enterprise Value
$243,467,856
Total Cash
$97,016,000
Total Debt
$17,255,000
Shares Out
27,184,933
Trailing EPS
$-0.98
Book Value
$3.39
ROE
-52.4%
ROA
-24.2%
Div Yield

Annual Trend (SEC EDGAR, last 3y)

Revenues vs Net Income (last 3y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 50,511,000 -30,574,000 -29,634,000 130,120,000 31,251,000 -28,977,000
Dec 2024 27,165,000 -24,122,000 -24,257,000 51,824,000 122,454,000 -25,466,000
Dec 2023 13,778,000 -18,591,000 -18,898,000 14,024,000 60,154,000 -17,480,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-1.44

Peers — same industry

TickerNameMarket CapLastDaily %
ELMD Electromed, Inc. $317.13M $38.30
CV CapsoVision, Inc $330.76M $6.62
SI SHOULDER INNOVATIONS, INC. $312.32M $15.06
CLPT ClearPoint Neuro, Inc. $354.48M $11.82
DCTH DELCATH SYSTEMS, INC. $373.87M $10.83

News headlines (Yahoo Finance, 1h cache)

Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?
2026-05-25 13:55 · Yahoo
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?
2026-05-22 13:40 · Yahoo
Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet
2026-05-08 13:55 · Yahoo
Here's What Analysts Are Forecasting For Carlsmed, Inc. (NASDAQ:CARL) After Its First-Quarter Results
2026-05-07 19:34 · Yahoo
Carlsmed Q1 Earnings Call Highlights
2026-05-05 23:43 · Yahoo
Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates
2026-05-05 22:05 · Yahoo
Carlsmed (CARL) Q1 2026 Earnings Transcript
2026-05-05 21:53 · Yahoo
Carlsmed® Reports First Quarter 2026 Financial Results
2026-05-05 20:01 · Yahoo
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
2026-04-28 20:01 · Yahoo
Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026
2026-04-14 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.